HopeStage
Back to all studies
CompletedNCT01545310

SLV354 and Brain Receptor Imaging in Healthy Adults and Schizophrenia

About this titleRead the official source — NCT01545310
Medication studyAges 18–55United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
New HavenSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2011
Recruitment status
Completed
Enrollment listed in the registry
18
Sponsor
Abbott
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT01545310
Official title
Show the full official title

An Open-Label, Positron Emission Tomography (PET) Study to Evaluate the Brain 5 HT6 Receptor Occupancy by Single Doses of SLV354 in Healthy Male Subjects and Subjects With Stable Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Abbott.

Did this study involve medication?

Yes. The study involved medication, including SLV354.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies